Company Filing History:
3 out of 277 
3 out of 479 
1 out of 9 Years Active: 1984-2016
Title: The Innovations of Chih-Sheng Chiang
Introduction
Chih-Sheng Chiang is a notable inventor based in Chatsworth, California. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and diagnostic methods. With a total of eight patents to his name, Chiang's work has had a profound impact on medical diagnostics and treatment.
Latest Patents
Chiang's latest patents include groundbreaking innovations such as "Monoclonal antibodies and diagnostic uses thereof." This patent focuses on antibodies targeting the preferentially expressed antigen in melanoma (PRAME) and the synovial sarcoma X breakpoint 2 (SSX-2) antigens. The disclosure outlines methods of use and diagnostic kits that utilize these antibodies. Another significant patent is "Fluorescence energy transfer by competitive hybridization," which provides a method for detecting nucleotides or monitoring nucleotide amplification through fluorescence energy transfer. This method employs unequal length complementary probes, enhancing the detection process.
Career Highlights
Throughout his career, Chih-Sheng Chiang has worked with prominent companies in the biotechnology sector. Notable among these are Mannkind Corporation and Quest Diagnostics Investments, Inc. His experience in these organizations has contributed to his expertise and innovation in the field.
Collaborations
Chiang has collaborated with several professionals in his field, including Jose F. Cuan and Nathalie Kertesz. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.
Conclusion
Chih-Sheng Chiang's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to advance the field of medical diagnostics and treatment, showcasing the importance of innovation in healthcare.